Previous symbols: C1orf7, CIAS1, DFNA34. Aliases: AGTAVPRL, AII, AVP, FCAS, FCU, NALP3, PYPAF1, MWS, CLR1.1.
NLRP3 (cryopyrin) is a cytosolic NLR-family protein of myeloid and other innate immune cells that nucleates the NLRP3 inflammasome, the platform that activates caspase-1 and so drives maturation of interleukin-1 beta and interleukin-18 and gasdermin-D-dependent pyroptosis. It is built from an N-terminal pyrin domain, a central nucleotide-binding NACHT domain and a C-terminal leucine-rich repeat. In the resting state it is held as an autoinhibited, ADP-bound, membrane-binding oligomeric cage - reported as a decamer and as a dodecamer by different groups - with the pyrin domains sequestered inside the leucine-rich-repeat shell. Activation converts the NACHT domain to an ATP-bound conformation and assembles an active disc in which the pyrin domains stack into a filament that nucleates unidirectional polymerisation of the adaptor ASC, which in turn recruits procaspase-1. NLRP3 has no established direct agonist ligand. It responds to an unusually wide range of stimuli - pore-forming toxins, extracellular ATP, crystals such as monosodium urate, silica and alum, cell swelling, and mitochondrial and lysosomal damage - and the prevailing view is that it detects a shared downstream cellular perturbation, with potassium efflux and disassembly of the trans-Golgi network as common intermediates, rather than binding each agonist. Recruitment to the dispersed trans-Golgi network occurs through ionic interaction between a conserved polybasic region and phosphatidylinositol-4-phosphate, after which microtubule-dependent transport concentrates NLRP3, together with the kinase NEK7, as condensates at the pericentriolar material of the microtubule organising centre. Whether this route is obligatory is disputed: low-molecular-weight, non-cage NLRP3 species can drive a slower, trans-Golgi- and MTOC-distal pathway that dominates in human neutrophils, and raising NLRP3 abundance can make potassium-efflux-driven activation independent of both NEK7 and priming. Gain-of-function mutations, mostly in the NACHT-encoding exon 3, cause the cryopyrin-associated periodic syndromes - familial cold autoinflammatory syndrome, Muckle-Wells syndrome and neonatal-onset multisystem inflammatory disease - which respond to interleukin-1 blockade, and NLRP3 activity contributes to gout, atherosclerosis, silicosis and neuroinflammation. A separate, inflammasome-independent role for NLRP3 as a nuclear transcriptional cofactor that binds the Il4 promoter with IRF4 in T helper 2 cells has been reported in mouse but is not independently corroborated.
Relationship is the entry's genetic[].relationship_type. untyped means the entry has a genetic record for the gene but does not type it; its free-text association is shown instead.
| Disorder | Relationship | Where the gene appears |
|---|---|---|
| Familial Cold Autoinflammatory Syndrome | causative germline |
mechanism: Constitutive NLRP3 inflammasome activation; NLRP3 gain-of-function mutation
subtype: FCAS1
scoped to subtype: FCAS1
|
| Hearing Loss Autosomal Dominant 34 With or Without Inflammation | causative germline gain of function |
mechanism: NLRP3 Gain-of-Function Variant
|
| Pyoderma Gangrenosum | susceptibility | |
| Alzheimer Disease |
untyped
Genetic Variant
|
mechanism: Neuroinflammation
|
| Chronic_Obstructive_Pulmonary_Disease |
untyped
Inflammasome activation contributes to chronic inflammation.
|
|
| CINCA Syndrome |
untyped
Causative
|
mechanism: NLRP3 gain-of-function mutation
variant: NLRP3 NACHT-domain gain-of-function missense substitutions (de novo)
|
| Kawasaki Disease |
untyped
NLRP3 inflammasome activation leads to IL-1β release and pyroptosis
|
mechanism: Immune Response Dysregulation
|
| Muckle-Wells Syndrome |
untyped
Causative
germline
gain of function
|
mechanism: NLRP3 gain-of-function activation
|
| Atrial Fibrillation | no genetic record |
mechanism: Fibroblast NLRP3 Inflammasome Activation
animal model: Mouse (Mus musculus)
|
| Bacterial meningitis | no genetic record |
mechanism: Inflammasome Activation and Pyroptosis
|
| Leptospirosis | no genetic record |
mechanism: NLRP3 inflammasome complex assembly
|
| Majeed Syndrome | no genetic record |
mechanism: Loss of Lipin-2 Restraint on the NLRP3 Inflammasome
|
| Major Depressive Disorder | no genetic record |
animal model: Gsdmd, Casp1 and astrocytic Nlrp3 knockout mice under chronic mild stress
|
| Multiple Sclerosis | no genetic record |
mechanism: Microglial NLRP3 Inflammasome Activation
|
Identity from HGNC (snapshot 2026-10-01). Page layers are described in the gene pages documentation.